John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois, 60612, United States
NCT Number: NCT01330121
The purpose of the study is to evaluate patient adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
It is a prospective, randomized, controlled Study. Patients randomized in a 1:1 ratio to pharmacist counseling or standard of therapy prior to discharge.
Standard therapy: Nurses distribute a education pamphlet on diabetes.
Pharmacist Counseling includes but is not limited to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic & non-glycemic goal levels Explaining the importance of compliance with medications & appointments Educating on the basics of nutrition and physical activity
Time frame: up to 120 days
The primary efficacy endpoint will be the difference in rate of adherence with medications Adherence will be assessed at 30, 60, 90, and 120 days following discharge An average of the total adherence rate 120 days following discharge will be calculated as the primary outcome measure
Time frame: up to 90 days
A1c measure as % and lipid panel 90 days following pharmacist counseling
Time frame: up to 90 days
BP in mm/Hg
Time frame: up to 90 days
Lipid measurements in mg/dL
Cook County Health
Other Gov
Pharmacist Discharge Counseling: Bridging the Gap by Transitional Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05330247
Body Weight, Diabetes Mellitus
Copenhagen, Copenhagen NV, Denmark
View Trial DetailsNCT07677865
Alzheimer Disease, Body Weight
Chengdu, Sichuan, China
View Trial DetailsNCT06638099
Diabetes, Diabetes Mellitus
El Centro, California, United States
View Trial DetailsNCT07647406
Diabetes Mellitus, Diabetes Mellitus Type 2
Pančevo, Vojvodina, Serbia
View Trial Details